Apraclonidine Hydrochloride and Trastuzumab and Hyaluronidase
Determining the interaction of Apraclonidine Hydrochloride and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine ophthalmic, Apraclonidine
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine Hydrochloride-Trastuzumab Injection (Intravenous)
- Apraclonidine Hydrochloride-Trastuzumab Intravenous
- Apraclonidine Hydrochloride-Trastuzumab-anns
- Apraclonidine Hydrochloride-Trastuzumab-dkst
- Apraclonidine Hydrochloride-Trastuzumab-dkst Intravenous
- Apraclonidine Hydrochloride-Trasylol
- Trastuzumab and Hyaluronidase-Apraclonidine ophthalmic
- Trastuzumab and Hyaluronidase-Apremilast
- Trastuzumab and Hyaluronidase-Aprepitant
- Trastuzumab and Hyaluronidase-Aprepitant Capsules
- Trastuzumab and Hyaluronidase-Aprepitant Injection
- Trastuzumab and Hyaluronidase-Aprepitant Intravenous